| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Revenue | $436 | -35.1% |
| R&D Expense | $858K | -36.5% |
| SG&A Expense | $943K | +5.6% |
| Operating Income | -$5.3M | +39.9% |
| Net Income | -$4.2M | +49.6% |
| EPS (Basic) | -$1.43 | +65.5% |
| EPS (Diluted) | -$1.43 | +65.5% |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $1.2M | +25.5% |
| Short-term Investments | $3.0M | -43.6% |
| Accounts Receivable | $207 | +13.1% |
| Current Assets | $4.3M | -32.7% |
| Total Assets | $5.4M | -17.4% |
| Current Liabilities | $630K | +55.0% |
| Total Liabilities | $630K | +55.0% |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$4.4M | +32.8% |
| Capital Expenditures | $49K | +0.0% |
| Investing Cash Flow | $2.2M | -63.7% |
| Financing Cash Flow | $2.4M | +701.3% |
| Free Cash Flow | -$4.4M | +32.5% |
| Stockholders' Equity |
| $6.9M |
| +12.8% |